Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Sernova Corp > 100 cans of tuna
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Comment by Mercuryfilling1on Jun 30, 2022 6:59pm
235 Views
Post# 34795331

RE:RE:RE:100 cans of tuna

RE:RE:RE:100 cans of tunaYou know, I get that IR departments tread a fine line (from Investopedia: "For example, IR departments have to lead companies in quiet periods, where it is illegal to discuss certain aspects of a company and its performance.") and the fact they're tightly integrated and constrained by legal, financial and managerial aspects... BUT that seems to have no effect on characters like Shapiro who are out there sporting their white lab coats and outflanking Phil and crew at every PR turn. They seem  totally unconstrained by IR standards and quite willing to use multiple platforms and messaging to get their company name in the spotlight. Maybe a little less IR and a little more PR would help? Dunno. Time for some Irish.
Enjoy the weekend.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities